Publications by the researcher in collaboration with Francisco Javier Escalada San Martín (22)

2021

  1. Endocrine disorders and psychiatric manifestations

    Endocrinology (Switzerland) (Springer Science and Business Media Deutschland GmbH), pp. 311-345

  2. Obesity and COVID-19. A necessary position statement

    Endocrinologia, Diabetes y Nutricion, Vol. 68, Núm. 8, pp. 573-576

  3. Resting energy expenditure is not altered in children and adolescents with obesity. Effect of age and gender and association with serum Leptin levels

    Nutrients, Vol. 13, Núm. 4

2019

  1. Discriminatory ability of anthropometric measurements of central fat distribution for prediction of post-prandial hyperglycaemia in patients with normal fasting glucose: The DICAMANO Study NCT03506581 NCT

    Journal of Translational Medicine, Vol. 17, Núm. 1

2018

  1. High Body Adiposity Drives Glucose Intolerance and Increases Cardiovascular Risk in Normoglycemic Subjects

    Obesity, Vol. 26, Núm. 4, pp. 672-682

2017

  1. Control de los factores de riesgo cardiovascular en diabetes tipo 2 en una consulta monográfica

    Anales del sistema sanitario de Navarra, Vol. 40, Núm. 3, pp. 413-420

  2. Dissociation of body mass index, excess weight loss and body fat percentage trajectories after 3 years of gastric bypass: Relationship with metabolic outcomes

    International Journal of Obesity, Vol. 41, Núm. 9, pp. 1379-1387

  3. Is HOMA-IR a potential screening test for non-alcoholic fatty liver disease in adults with type 2 diabetes?

    European Journal of Internal Medicine, Vol. 41, pp. 74-78

2015

  1. Cardiometabolic Profile Related to Body Adiposity Identifies Patients Eligible for Bariatric Surgery More Accurately than BMI

    Obesity Surgery, Vol. 25, Núm. 9, pp. 1594-1603

2014

  1. GLP-1 agonism stimulates brown adipose tissue thermogenesis and browning through hypothalamic AMPK

    Diabetes, Vol. 63, Núm. 10, pp. 3346-3358

  2. ¿Existe mayor riesgo de diabetes gestacional en pacientes con disfunción tiroidea autoinmune?

    Endocrinologia y Nutricion, Vol. 61, Núm. 7, pp. 377-381

2013

  1. Cardiotrophin 1 protects beta cells from apoptosis and prevents streptozotocin-induced diabetes in a mouse model

    Diabetologia, Vol. 56, Núm. 4, pp. 838-846

  2. Erratum: Cardiotrophin 1 protects beta cells from apoptosis and prevents streptozotocin-induced diabetes in a mouse model (Diabetologia DOI 10.1007/s00125-012-2822-8)

    Diabetologia

2012

  1. Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity

    International Journal of Obesity, Vol. 36, Núm. 2, pp. 286-294

  2. Clinical usefulness of a new equation for estimating body fat

    Diabetes Care, Vol. 35, Núm. 2, pp. 383-388

2011

  1. Body adiposity and type 2 diabetes: Increased risk with a high body fat percentage even having a normal BMI

    Obesity, Vol. 19, Núm. 7, pp. 1439-1444

2010

  1. Capítulo 30. El laboratorio en las enfermedades endocrinológicas

    La clínica y el laboratorio: interpretación de análisis y pruebas funcionales, exploración de los síndromes, cuadro biológico de las enfermedades (Elsevier Masson), pp. 587-628

  2. El índice de masa corporal y la circunferencia abdominal infraestiman el diagnóstico de obesidad en pacientes con diabetes mellitus tipo 2

    Avances en Diabetologia, Vol. 26, Núm. 3, pp. 173-177

  3. Importancia del control del peso en el deterioro metabólico de la diabetes tipo 2

    Avances en Diabetologia, Vol. 26, Núm. 3, pp. 151-155

2009

  1. La actividad física determinada mediante acelerometría es menor en los pacientes obesos

    Trauma, Vol. 20, Núm. 2, pp. 83-91